Gestational glucose tolerance and cord blood leptin levels predict slower weight gain in early infancy

Margaret Parker1, Sheryl L Rifas-Shiman, Mandy B Belfort

  • 1Division of Newborn Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA, USA. margaret.parker@childrens.harvard.edu

The Journal of Pediatrics
|September 22, 2010
PubMed

Insights

Prenatal factors like higher neonatal leptin and gestational diabetes predict slower infant weight gain. These findings suggest the intrauterine hormonal environment influences early growth and potential later obesity.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Background:

  • Childhood obesity is a growing public health concern.
  • Identifying early predictors of infant growth is crucial for prevention strategies.
  • Prenatal and perinatal factors are increasingly recognized for their role in infant development.

Purpose of the Study:

  • To investigate if known predictors of childhood obesity also forecast weight gain in early infancy.
  • To analyze the association between specific maternal and infant factors and infant weight change.

Main Methods:

  • Prospective cohort study of 690 infants (Project Viva).
  • Measurement of infant length and weight at birth and 6 months.
  • Multivariable linear regression to assess factors influencing weight-for-length z-score (WFL-z) change from 0 to 6 months.

Main Results:

  • Mean WFL-z change was 0.23 (1.11) from birth to 6 months.
  • Higher birth weight-for-gestational age z-score, cord blood leptin, and gestational diabetes were associated with slower WFL-z gain.
  • Specifically, each unit increase in birth weight-for-gestational age z-score, per 10 ng/mL increase in cord blood leptin, and having gestational diabetes predicted slower weight gain.

Conclusions:

  • Elevated neonatal leptin and gestational diabetes mellitus are linked to reduced weight gain in the first six months of life.
  • The intrauterine hormonal environment may significantly shape early infant growth trajectories.
  • These early growth patterns could potentially influence the risk of developing obesity later in life.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes: